{
    "id": 29314,
    "fullName": "CCND1 E36K",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "CCND1 E36K lies within the cyclin-N terminal domain of the Ccnd1 protein (UniProt.org). E36K is associated with resistance to Imbruvica (ibrutinib) (PMID: 27713153), and results in increased protein expression and stability due to defective proteolysis as demonstrated by decreased phosphorylation of threonine-286 compared to wild-type Ccnd1 in culture (PMID: 27713153), and therefore, is predicted to lead to a gain of Ccnd1 protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 14006,
                    "pubMedId": 27713153,
                    "title": "CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27713153"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 595,
        "geneSymbol": "CCND1",
        "terms": [
            "CCND1",
            "BCL1",
            "D11S287E",
            "PRAD1",
            "U21B31"
        ]
    },
    "variant": "E36K",
    "createDate": "02/07/2019",
    "updateDate": "04/24/2019",
    "referenceTranscriptCoordinates": {
        "id": 178231,
        "transcript": "NM_053056",
        "gDna": "chr11:g.69641419G>A",
        "cDna": "c.106G>A",
        "protein": "p.E36K",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15916,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, mantle cell lymphoma cells expressing CCND1 E36K demonstrated resistance to treatment with Zydelig (idelalisib) in culture (PMID: 27713153).",
            "molecularProfile": {
                "id": 31314,
                "profileName": "CCND1 E36K"
            },
            "therapy": {
                "id": 1023,
                "therapyName": "Idelalisib",
                "synonyms": null
            },
            "indication": {
                "id": 50746,
                "name": "mantle cell lymphoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 14006,
                    "pubMedId": 27713153,
                    "title": "CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27713153"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15920,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, mantle cell lymphoma cells expressing CCND1 E36K demonstrated resistance to treatment with Torkinib (PP242) in culture (PMID: 27713153).",
            "molecularProfile": {
                "id": 31314,
                "profileName": "CCND1 E36K"
            },
            "therapy": {
                "id": 2240,
                "therapyName": "Torkinib",
                "synonyms": null
            },
            "indication": {
                "id": 50746,
                "name": "mantle cell lymphoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 14006,
                    "pubMedId": 27713153,
                    "title": "CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27713153"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15913,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, mantle cell lymphoma cells expressing CCND1 E36K demonstrated resistance to treatment with Imbruvica (ibrutinib) in culture (PMID: 27713153).",
            "molecularProfile": {
                "id": 31314,
                "profileName": "CCND1 E36K"
            },
            "therapy": {
                "id": 768,
                "therapyName": "Ibrutinib",
                "synonyms": null
            },
            "indication": {
                "id": 50746,
                "name": "mantle cell lymphoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 14006,
                    "pubMedId": 27713153,
                    "title": "CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27713153"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31314,
            "profileName": "CCND1 E36K",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 178231,
            "transcript": "NM_053056",
            "gDna": "chr11:g.69641419G>A",
            "cDna": "c.106G>A",
            "protein": "p.E36K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}